Last reviewed · How we verify
NCT05210712
Respiratory Rate Validation Study - RS001.2 Respiree Cardio-Respiratory Monitor
trial testing RS001.2 Respiree Cardio-Respiratory Monitor in A Minimum of 30 Adults, Ages 18 Years and Older in 30 participants. Completed in 10 February 2022.
10 February 2022
Quick facts
| Lead sponsor | Respiree Pte Ltd |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 24 January 2022 |
| Primary completion | 10 February 2022 |
| Estimated completion | 10 February 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- RS001.2 Respiree Cardio-Respiratory Monitor
Conditions studied
- A Minimum of 30 Adults, Ages 18 Years and Older — all drugs for A Minimum of 30 Adults, Ages 18 Years and Older →
Sponsor
Respiree Pte Ltd
Who can join
18 and older, any sex, with A Minimum of 30 Adults, Ages 18 Years and Older. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to conduct a Respiratory Rate accuracy validation comparing the RS001.2 Respiree Cardio-Respiratory Monitor to the Reference, an FDA cleared End Tidal Carbon Dioxide monitor (GE Datex-Ohmeda).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05210712
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Respiree Pte Ltd trials
Trials by the same sponsor.
- NCT06798688 — In This Study, the Sponsor Would Like to Collaborate with Institution and Investigator to Aggregate Participants Data an · not yet recruiting
- NCT05139693 — Accuracy of Pulse Oximeters With Profound Hypoxia · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05210712 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Respiree Pte Ltd
- Last refreshed: 2 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05210712.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing